EP Patent

EP1725569A1 — Prodrugs of piperazine and substituted piperidine antiviral agents

Assigned to Bristol Myers Squibb Co · Expires 2006-11-29 · 19y expired

What this patent protects

This invention provides for prodrug Compounds (I), pharmaceutical compositions thereof, and their use in treating HIV infection. Also, this invention provides for intermediate Compounds (II) useful in making prodrug Compounds (I).

USPTO Abstract

This invention provides for prodrug Compounds (I), pharmaceutical compositions thereof, and their use in treating HIV infection. Also, this invention provides for intermediate Compounds (II) useful in making prodrug Compounds (I).

Drugs covered by this patent

fostemsavir-tromethamine (FOSTEMSAVIR TROMETHAMINE)

Patent Metadata

Patent number: EP1725569A1
Jurisdiction: EP
Classification: —
Expires: 2006-11-29
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.